Yong Lim

Yuyu Pharma

Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis. Currently, Yuyu Pharma has two new drug discovery programs targeting benign prostatic hyperplasia (BPH) and dry eye syndrome. Yuyu Pharma also has various Over-the-counter drugs and dietary supplements, such as YupanC® (vitamin C), Venoplus® (ointment), and Venapollo® (multivitamins)